![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 9/20 | (2006.01) |
A61K 9/28 | (2006.01) | ||
A61K 9/48 | (2006.01) | ||
A61K 9/16 | (2006.01) | ||
A61K 31/00 | (2006.01) | ||
A61K 31/444 | (2006.01) |
(11) | Number of the document | 3716952 |
(13) | Kind of document | T |
(96) | European patent application number | 18815293.8 |
Date of filing the European patent application | 2018-11-28 | |
(97) | Date of publication of the European application | 2020-10-07 |
(45) | Date of publication and mention of the grant of the patent | 2022-01-05 |
(46) | Date of publication of the claims translation | 2022-04-11 |
(86) | Number | PCT/GB2018/053443 |
Date | 2018-11-28 |
(87) | Number | WO 2019/106361 |
Date | 2019-06-06 |
(30) | Number | Date | Country code |
201762592242 P | 2017-11-29 | US | |
201721515 | 2017-12-21 | GB |
(72) |
COLLETT, John Herman , GB
COOK, Gary Paul , US
FARRAR, Jamie Joseph , GB
FRODSHAM, Michael John , GB
ROE, Michael Bryan , GB
TODD, Richard Simon , GB
WARD, Robert Neil , GB
|
(73) |
Kalvista Pharmaceuticals Limited ,
Porton Science Park
Bybrook Road, Porton Down, Salisbury SP4 0BF
Wiltshire,
GB
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Vaisto formos, apimančios plazmos kalikreino inhibitorių |
DOSAGE FORMS COMPRISING A PLASMA KALLIKREIN INHIBITOR |
Payment date | Validity (years) | Amount | |
2024-10-24 | 7 | 162.00 EUR |
2025-11-28 |